The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia

François, BrunoChastre, JeanEggiman, PhilippeLaterre, Pierre-FrançoisTorres Martí, AntoniSanchez, MiguelEsser, Mark T.Bishop, BrianBonten, MarcGoosens, HermanJafri, Hasan S.2020-05-152020-05-152016-08-151058-4838https://hdl.handle.net/2445/160518The Innovative Medicines Initiative-funded COMBACTE consortium fosters academic-industry partnership in pioneering studies to combat serious bacterial infections. We describe how this partnership is advancing the development of 2 monoclonal antibodies, MEDI4893 and MEDI3902, for the prevention of nosocomial pneumonia.1 p.application/pdfeng(c) François, Bruno et al., 2016PneumòniaAssaigs clínics de medicamentsPneumoniaDrug testingThe SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumoniainfo:eu-repo/semantics/article6652432020-05-15info:eu-repo/semantics/openAccess